Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,117.55, giving the company a market capitalization of 1.05T. It carries a P/E multiple of 38.16 and pays a dividend yield of 0.60%.
On 2026-09-11, Eli Lilly(LLY) stock traded between a low of $1,113.01 and a high of $1,131.18. Shares are currently priced at $1,117.55, which is +0.4% above the low and -1.2% below the high.
The Eli Lilly(LLY)'s current trading volume is 1.83M, compared to an average daily volume of 2.44M.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
LLY News
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study, officially titled “Tirzepatide Study of Renal Function in People Wi...
Eli Lilly & Co. (NYSE:LLY) is reportedly preparing to expand into the women’s health sector. The pharmaceutical giant is gathering specialists and researching...
U.S. pharmaceutical giant Eli Lilly (LLY) has announced that it completed its acquisition of AtaiBeckley (ATAI), a biopharmaceutical company developing treatmen...
Analyst ratings
81%
of 32 ratingsMore LLY News
Eli Lilly and Company (LLY) announced the successful completion of its acquisition of AtaiBeckley (ATAI). AtaiBeckley is a clinical-stage biopharmaceutical comp...
Novo Nordisk shares (NVO) fell by 2% to about $43 early Friday after Morgan Stanley analyst Thibault Boutherin downgraded the Danish pharma giant from Hold to S...
Eli Lilly and Nvidia both just posted stunning quarters riding two of the biggest secular waves in markets today, but a $10,000 bet can only tilt one way. Which...
Eli Lilly just crossed the trillion-dollar threshold on the back of a GLP-1 empire growing at nearly 50% annually, but a recent pullback and rising risks are fo...
HSBC raised the firm’s price target on Eli Lilly (LLY) to $940 from $850 and keeps a Reduce rating on the shares. The firm adjusted targets in the healthcare gr...
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...
Eli Lilly & Co. (NYSE:LLY) stock is down about 2% on Tuesday as a broader risk-off move pressures large-cap healthcare stocks. The Nasdaq is down 0.29%, while t...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.